Furthermore, CPAP therapy, a fundamental treatment strategy in OSA also in view of its antioxidant effects, have shown to have little effect on SOD concentrations, in contrast to oxidative stress markers such as 8-isoprostane and 8-hydroxy-2-deoxyguanosine [15]. This evidence concerns the gene SOD1 and obstructive sleep apnea syndrome.